glp 1 and kidney transplant Glp-1 receptor agonists: A boon for recipients? GLP-1 drugs may extend life,

Important for correct interpretation: these figures are body-weight-based animal doses and cannot be transferred to humans

YouGov Profiles data shows that 51% of Americans taking GLP-1 drugs are aged 55 or older, compared with 38% of the nationally representative population

[DOI] [PMC free article] [PubMed] [Google Scholar] [63].Kong SE, Blennerhassett LR, Heel KA, McCauley RD, Hall JC

Preclinical and early exploratory research has used ARA-290 to investigate innate-repair receptor engagement in models relevant to small-fiber damage associated with systemic inflammatory conditions

Below we compare the major differences, pros and cons, and real-world considerations so you can make an informed choice with your provider